ACA
NRXS icon

Apis Capital Advisors’s Neuraxis NRXS Stock Holding History

Apis Capital Advisors’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-124,024
Closed -$300K – 59
2025
Q2 		$300K Buy
+124,024
New +$291K 0.11% 40

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Apis Capital Advisors's NRXS Position: Q3 2025 in Review

Apis Capital Advisors sold out of Neuraxis (NRXS) in Q3 2025, closing a stake of 124,024 shares — an estimated $300K sold.

Apis Capital Advisors first reported a position in NRXS in Q2 2025 and held it in 1 quarter. The position peaked at $300K in Q2 2025. 18 funds tracked by Wall St. Rank hold NRXS as of Q3 2025.

  • Apis Capital Advisors reported no remaining Neuraxis position as of Q3 2025 after selling out during the quarter.
  • Apis Capital Advisors sold 124,024 Neuraxis shares in Q3 2025, an estimated $300K.
  • Apis Capital Advisors first reported a position in Neuraxis in Q2 2025 and held it in 1 quarter.
  • Apis Capital Advisors's Neuraxis position peaked at $300K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Neuraxis as of Q3 2025.

Based on Apis Capital Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.